Skip to main content

Table 1 Clinicopathological data MS patients and control subjects (qPCR study)

From: Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients

Case

Gender

Age

PMD (h)

DD

MS Type

Demyelination

COD

MS

       

1

F

58

7.3

13

RR

no

Abdominal Adenocarcinoma

2

F

54

5.9

37

SP

no

Unknown Infection

3

M

63

4.9

36

PP

no

Sepsis

4

F

54

7.1

5

SP

no

Drug Overdose

5

F

51

7.0

15

PP

no

Attempted Suicide (asphyxiation)

6

F

73

7.0

46

PP

yes

Dehydration/Gastroenteritis

7

F

46

5.6

14

SP

yes

Unknown

8

M

52

6.7

30

SP

yes

Pulmonary Infections

9

F

40

5.4

13

SP

yes

Pneumonia

10

F

66

13.0

35

SP

yes

Unknown

Control

       

1

M

65

8.5

   

Cardiac arrest

2

F

53

36.0

   

Cardiac thrombosis

3

F

52

12.0

   

Polymicrobial sepsis

4

M

53

12.0

   

Myocardial infarct

5

M

77

12.0

   

Mesenteric bleeding

  1. PMD = Postmortem delay; DD = Disease duration; COD = Cause of death; SP = Secondary progressive; PP = Primary progressive.